Pharma & Biotech

Shares of Oncology Institute demonstrated significant strength in Monday's trading session, propelled by the company's announcement of substantial cost savings...

Alector Inc finds itself at a pivotal moment as the biotechnology firm prepares to report crucial clinical trial data for...

Biotechnology firm Arvinas has unveiled a significant strategic overhaul, involving the potential out-licensing of a key breast cancer drug and...

Viking Therapeutics experienced significant selling pressure yesterday as investors reacted to Pfizer's unexpected acquisition of competitor Metsera. The biotech firm's...

Bayer's subsidiary AskBio has initiated a European Phase II clinical trial for its innovative gene therapy candidate, AB-1005, targeting Parkinson's...

Idorsia Ltd. shares are demonstrating notable strength in today's trading session, propelled by two significant strategic developments that are prompting...

Shares of Reviva Pharmaceuticals Holdings have been on a rollercoaster ride after the company disclosed the completion of a public...

The inclusion of Compass Therapeutics in the S&P Biotechnology Select Industry Index represents a significant validation for the clinical-stage biotech...

A previously under-the-radar biotechnology firm, Astria Therapeutics, is now commanding significant market attention following the release of encouraging early-stage clinical...

Iovance Biotherapeutics has made a significant corporate announcement, detailing the issuance of new stock options. This move directly impacts the...